✦ LIBER ✦

A phase II study of Gemcitabine (G) plus Docetaxel (D) as first line chemotherapy for advanced NSCLC patients (PTS)

✍ Scribed by Ventriglia, M; Estevez, R; Cabrera, L; Spector, C; Álvarez, A.A; Cilurzo, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-531 Phase II study of sequential gemci

✍ Chiappori, Alberto; Simon, George; Lima, Caio Rocha; Williams, Charles; Haura, E 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Gemcitabine and docetaxel as first-line

✍ Ardavanis, A; Tryfonopoulos, D; Alexopoulos, A; Kandylis, C; Lainakis, G; Rigato 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

A phase II study: docetaxel as first-lin

✍ P. Rougier; A. Adenis; M. Ducreux; M. de Forni; J. Bonneterre; M. Dembak; P. Clo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Gemcitabine plus docetaxel as first-line

✍ Joaquín Casal; Margarita Amenedo; José Ramón Mel; Luis Miguel Antón; Rubén Rodrí 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 343 KB

Docetaxel plus gemcitabine as front-line

✍ Boukovinas, I.; Souglakos, J.; Hatzidaki, D.; Kakolyris, S.; Ziras, N.; Vamvakas 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Phase II study of gemcitabine plus oxali

✍ Cappuzzo, F; Novello, S; De Marinis, F; Franciosi, V; Maur, M; Ceribelli, A; Lor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB